Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Cunningham

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Molecular Genetics and Metabolism|May 12, 2012
Recommendations for the use of sapropterin in phenylketonuriaAmy Cunningham, Heather Bausell, Mary Brown, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|March 26, 2026
Gadolinium Intermediate Elimination and Persistent Symptoms After Magnetic Resonance Imaging Contrast Agent ExposureBrent Wagner, Olivia X Jastrzemski, Sasha R Vigil, et al.
The Oncologist|May 16, 2019
Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent CancerChristopher S Nabel, Mariano Severgnini, Yin P Hung, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 16, 2021
Predictors of Rheumatic Immune-Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for CancerAmy Cunningham-Bussel, Jiaqi Wang, Lauren C Prisco, et al.
The Journal of Experimental Medicine|September 10, 2009
NOD2 regulates hematopoietic cell function during graft-versus-host diseaseOlaf Penack, Odette M Smith, Amy Cunningham-Bussel, et al.
Cancer|April 26, 2017
Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 studyEytan Ben-Ami, Constance M Barysauskas, Sarah Solomon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2012
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobialsBen Gold, Maneesh Pingle, Steven J Brickner, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Molecular Genetics and Metabolism|May 12, 2012
Recommendations for the use of sapropterin in phenylketonuriaAmy Cunningham, Heather Bausell, Mary Brown, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|March 26, 2026
Gadolinium Intermediate Elimination and Persistent Symptoms After Magnetic Resonance Imaging Contrast Agent ExposureBrent Wagner, Olivia X Jastrzemski, Sasha R Vigil, et al.
The Oncologist|May 16, 2019
Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent CancerChristopher S Nabel, Mariano Severgnini, Yin P Hung, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 16, 2021
Predictors of Rheumatic Immune-Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for CancerAmy Cunningham-Bussel, Jiaqi Wang, Lauren C Prisco, et al.
The Journal of Experimental Medicine|September 10, 2009
NOD2 regulates hematopoietic cell function during graft-versus-host diseaseOlaf Penack, Odette M Smith, Amy Cunningham-Bussel, et al.
Cancer|April 26, 2017
Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 studyEytan Ben-Ami, Constance M Barysauskas, Sarah Solomon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2012
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobialsBen Gold, Maneesh Pingle, Steven J Brickner, et al.
Pageof 8